Perspective Therapeutics (FRA:AAJ0) Other Current Liabilities: €3.35 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:AAJ0 Perspective Therapeutics Inc FRA:AAJ0
37 GF Score
Price €2.41
! 2 Warning Signs
View Full Analysis

What is Perspective Therapeutics Other Current Liabilities?

Perspective Therapeutics FRA:AAJ0 +1.43% 37 Other Current Liabilities is €3.35 Mil as of Mar. 2026. GuruFocus rates FRA:AAJ0 with a GF Score™ of 37/100. The stock has 2 warning signs investors should review.

Perspective Therapeutics's other current liabilities for the quarter that ended in Mar. 2026 was €3.35 Mil.

Perspective Therapeutics's quarterly other current liabilities increased from Sep. 2025 (€5.72 Mil) to Dec. 2025 (€6.40 Mil) but then declined from Dec. 2025 (€6.40 Mil) to Mar. 2026 (€3.35 Mil).

Perspective Therapeutics's annual other current liabilities increased from Jun. 2022 (€0.24 Mil) to Dec. 2023 (€7.94 Mil) but then declined from Dec. 2023 (€7.94 Mil) to Dec. 2024 (€5.23 Mil).

Perspective Therapeutics Other Current Liabilities Related Terms

Perspective Therapeutics Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Perspective Therapeutics's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Perspective Therapeutics Other Current Liabilities Chart

Perspective Therapeutics Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Dec23 Dec24
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.18 0.22 0.24 7.94 5.23

Perspective Therapeutics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.69 4.37 5.72 6.40 3.35
FRA:AAJ0
37GF Score
Perspective Therapeutics Inc FRA:AAJ0
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Perspective Therapeutics Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of €3.35 Mil mean?
Perspective Therapeutics (FRA:AAJ0) has a Other Current Liabilities of €3.35 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Perspective Therapeutics.
Is Perspective Therapeutics' Other Current Liabilities too high?
Perspective Therapeutics' current Other Current Liabilities is €3.35 Mil. Overall, Perspective Therapeutics has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does Perspective Therapeutics' Other Current Liabilities compare to CV and LAB?
Perspective Therapeutics' Other Current Liabilities of €3.35 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Medical Devices & Instruments company?
A good Other Current Liabilities depends on the Medical Devices & Instruments industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Perspective Therapeutics. Perspective Therapeutics's current Other Current Liabilities is €3.35 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Perspective Therapeutics stock overvalued right now?
Perspective Therapeutics (FRA:AAJ0) has a current Other Current Liabilities of €3.35 Mil. The current Other Current Liabilities is €3.35 Mil. Perspective Therapeutics' overall GF Score™ is 37/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Perspective Therapeutics (FRA:AAJ0), the current Other Current Liabilities is €3.35 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Perspective Therapeutics Business Description

Other Exchanges CATX:USA
Address 2401 Elliott Avenue, Suite 320, Seattle, WA, USA, 98121
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
37GF Score

Get the complete analysis for FRA:AAJ0

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.41
Price